Press release
Pregabalin Market to Witness Robust Expansion by 2029
According to the World Health Organization (WHO), in 2019, epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Additionally, almost 80% of people with epilepsy live in low and middle-income countries and up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. However, the risk of mortality is three times higher in people with epilepsy than in the general population. Hence the rising prevalence of epilepsy is driving the demand for pregabalin for treatment which in turn is boosting its market growth.
Some major players in the market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Cipla Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, Sawai announced the launch of the first generic version of the Lyrica pregabalin brand in Japan.
To Request a Sample of our Report on Pregabalin Market: https://www.omrglobal.com/request-sample/pregabalin-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Cipla Ltd., among others.
Pregabalin Market Report by Segment
By Type
Capsules
Oral Solutions
Others
By Application
Epilepsy
Neuropathic Pain
Anxiety Disorder
Others
A full Report of Pregabalin Market is Available @ https://www.omrglobal.com/industry-reports/pregabalin-market
Pregabalin Market Report by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pregabalin Market to Witness Robust Expansion by 2029 here
News-ID: 3270060 • Views: …
More Releases from Orion Market Research
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce …
In 2024, the global Business Analytics Market was valued at approximately USD 96.6 billion, and it is anticipated to expand to USD 196.5 billion by 2033, corresponding to a compound annual growth rate (CAGR) of around 7.8% between 2025 and 2033.
Business Analytics Market Overview
The Business Analytics Market is witnessing robust growth, driven by the proliferation of digital data and rising demand for real-time insights across sectors such as retail, healthcare,…
Bone and Joint Health Supplements Market Set to Witness Significant Growth by 20 …
In 2024, the global Bone and Joint Health Supplements Market was valued at approximately USD 15.63 billion, and it is projected to reach USD 22.93 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.6% from 2025 to 2030.
Bone and Joint Health Supplements Market Overview
The Bone and Joint Health Supplements Market is experiencing steady expansion as global aging and sedentary lifestyles contribute to increased prevalence of…
Image-guided Therapy Systems Market Set to Witness Significant Growth by 2033 | …
In 2024, the global Image-guided Therapy Systems Market was valued at approximately USD 6.12 billion, and it is expected to reach USD 10.08 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 5.7% from 2025 to 2033.
Image-guided Therapy Systems Market Overview
The Image-guided Therapy Systems Market is expanding steadily, driven by rising demand for minimally invasive surgical procedures and advances in imaging technologies. These systems integrate real-time…
Calcium Formate Market Set to Witness Significant Growth by 2033 | Zibo Ruibao C …
In 2024, the global Calcium Formate Market was valued at approximately USD 0.83 billion, and it is projected to reach approximately USD 1.47 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 5.9% from 2025 to 2033.
Calcium Formate Market Overview
The Calcium Formate Market is expanding steadily, driven primarily by its dual role as a concrete additive for faster curing and enhanced durability, and as an animal feed…
More Releases for Pregabalin
Global Pregabalin Oral Solution Market Size by Application, Type, and Geography: …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to Market Research Intellect, the global Pregabalin Oral Solution market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The global pregabalin oral solution market is experiencing steady growth, primarily due to the increasing prevalence of neuropathic pain and epilepsy. In 2023, the…
Global Pregabalin Oral Solution Market Size by Application, Type, and Geography: …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to Market Research Intellect, the global Pregabalin Oral Solution market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The pregabalin oral solution market is experiencing steady growth due to the increasing prevalence of neurological disorders, including epilepsy, neuropathic pain, and generalized anxiety…
Pregabalin: A Promising Drug for Pain Management and Neurological Disorders
Pregabalin [https://www.biofingredients.com/biof-supply-high-quality-pregabalin-powder-cas-148553-50-8-3s-aminomethyl-5-methylhexanoic-acid-product/], a medication primarily used for the treatment of neuropathic pain, anxiety disorders, and epilepsy, has been a subject of growing interest in the medical community due to its multifaceted benefits. As the global healthcare landscape continues to evolve, pregabalin's role in treating chronic pain and neurological conditions is becoming more evident, with new research shedding light on its effectiveness and expanding applications.
What is Pregabalin [https://www.biofingredients.com/biof-supply-high-quality-pregabalin-powder-cas-148553-50-8-3s-aminomethyl-5-methylhexanoic-acid-product/]?
Pregabalin, sold under the…
Pregabalin Market Insights: Growth, Trends, and Forecast (2024-2030)
𝐏𝐫𝐞𝐠𝐚𝐛𝐚𝐥𝐢𝐧'𝐬 𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐑𝐨𝐥𝐞 𝐢𝐧 𝐏𝐚𝐢𝐧 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐂𝐚𝐫𝐞
Pregabalin, a medication commonly used to treat neuropathic pain, fibromyalgia, and certain types of anxiety disorders, is seeing expanding demand across the globe. Its effectiveness in treating conditions such as epilepsy and chronic pain, along with growing awareness about mental health issues, is driving its market adoption.
Therapeutic Uses: Pregabalin is increasingly prescribed for neuropathic pain, diabetic neuropathy, post-herpetic neuralgia, and fibromyalgia, with…
Pregabalin Market: A Broad Understanding of Its Whereabouts
In a recently published Allied Market Research report, the global pregabalin market is expected to generate a revenue of $2.2 billion by 2032 with a CAGR of 3% from 2023 to 2032 from its estimated market value of $1.6 billion in 2022. The report offers a detailed study of market dynamics, trends, and updates of the industry, competitive landscape, and performances of key players along with their strategic moves.
Read…
Pregabalin Market Business Share, Size, New Opportunities and Forecast 2029
1.9.2023 : Pregabalin Market Expected to Reach USD 1029. 79 Billion by 2029, with 3.69 % CAGR
Pregabalin Market Report Scope and Research Methodology
Report Scope: This comprehensive research report delves into the Global Pregabalin Market, offering insights into market trends, growth drivers, challenges, and regional dynamics.
Research Methodology: Our research is based on a rigorous methodology that includes data analysis, industry surveys, and expert insights to provide a clear and accurate picture…
